Hold ACN at $188: widen stop to $178, replace restrictive five-condition add trigger with two achievable 25% tranches, add trim-50% rule below $155
Hold ACN without scaling in or trimming into the September binary catalyst. The MACD bearish divergence (price making higher highs at $189.76 vs $186.93, MACD rolling from peak 8.87 to 7.84, histogram compressing from +4.58 to negative over five weeks) combined with 200 SMA overhead rejection probability argues against spot adds. The structural floor (3.44% dividend yield, $9.6B capital return, net cash position) prevents Underweight. Collect carry while awaiting directional clarity; for concentrated holders, collar overlay defines risk through binary event.
| Position | Action |
|---|---|
| Pullback to $180-184 zone (10 EMA/VWMA confluence) with constructive price action AND MACD histogram turning back up | Add Tranche 1 (25% of intended exposure) |
| Daily close above $192.26 on volume >5M with MACD histogram re-expanding AND RSI holding >65 | Add Tranche 2 (additional 25% of intended exposure) |
| Price closes below $155 (50 SMA) on/around September Q4 FY26 earnings print | Trim 50% of position |
| Approach to $200-205 (fronting 200 SMA resistance), especially if RSI >70 with bearish divergence | Trim 25-30% of position |
Accenture at $188 represents a generational buying opportunity: a 24% ROE compounder trading at 12.83x forward earnings with revenue growth already reaccelerating to +5.6% and a 9-10% shareholder yield, not a value trap.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 200.97 | bearish |
| close_50_sma | 156.33 | bullish |
| close_10_ema | 184.30 | bullish |
| rsi | 64.47 | neutral |
| macd | 7.84 | bearish |
| macdh | -0.01 | bearish |
| boll_ub | 192.58 | bearish |
| boll_lb | 166.85 | bullish |
| atr | 7.11 | neutral |
| vwma | 181.51 | bullish |
Support: 184.3 · 181.51 · 179.72 · 169.98 · 166.85 · 156.33 · 120 · 126 | Resistance: 192.58 · 200.97 · 189.76
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Daily close above $192.26 on volume >5M with MACD histogram re-expanding AND RSI >65
Then: Add 25% of intended exposure
↩ rebuts: “Bear anchoring to trough quarters and claiming revenue growth is still deteriorating”
EV: +6.4% to +22.3% (target $200 to $220-230) · concedes: Higher-for-longer interest rates are a valid concern; Large-enterprise discretionary spend is not thawing; Recession remains a tail risk (8% probability); The stock did rally 60% from lows; MACD divergence is a valid technical observation for short-term traders
ACN's low valuation reflects structural decline, not a buying opportunity—the market is correctly pricing in deteriorating revenue growth, $25.32B in goodwill impairment risk, AI cannibalization of Accenture's own service lines, and a technical setup that confirms a bear market rally at the 61.8% Fibonacci retracement with no base-building above the 200 SMA.
· concedes: ROE of 24.4% is genuinely excellent; Q3 FY26 operating margin (17.0%) is technically higher than Q3 FY25 (16.8%); The 200 SMA at $200.97 is a target, not just resistance; Dividend yield of 3.44% is real income
→ vs conservative: MACD divergence at minus 0.01 is six-day-old noise; treating powerful V-shaped recovery as bear market rally anchors to June fear rather than structural reacceleration
→ vs conservative: $25B goodwill from McCoy and COMWARE acquisitions is strategic weapon for AI-SAP modernization, not impairment risk; conservative treats balance sheet as static
→ vs neutral: Implied vol and macro headwinds are excuses to sit out; ATR of 7.11 has compressed from post-shock regime and vol is a feature when buying quality at a discount
→ vs neutral: Conditional add at 25-33% on close above 201 is too restrictive; risk-adjusted entry at 188 with tight supports at 184/181 is compelling enough to scale in now
ACN underwent a dramatic 13-month journey including a topping pattern through late 2025, a structural breakdown beginning February 2026, and a gap-down shock on June 18, 2026 (41.7M shares vs typical 4-7M). The stock has since recovered ~57% from ~$122.96 to $188.09, but is at a critical inflection point: price sits 2.1% above the 10 EMA and 20.3% above the 50 SMA (bullish short-term structure) while remaining 6.4% below the 200 SMA (bearish long-term structure). MACD has formed a bearish divergence (peaked at +8.87 on Aug 13, now 7.84 with histogram at -0.01), and the Aug 31 high of $189.76 failed to close above the Bollinger upper band ($192.58). The report rates the overall stance as HOLD, recommending existing positions be held with a trailing stop near $174 and new entrants wait for a pullback to $180-$184 or a confirmed breakout above $200.97. Volume during the recovery has been moderate (4-7M), indicating steady accumulation rather than explosive buying. The June 18 gap-down zone ($120-$126) represents critical support below the current recovery rally.
Market Cap
$115.10 B
Share Price
~$188
52-Week High
$291.09
52-Week Low
$118.15
50-Day Moving Average
$156.73
200-Day Moving Average
$204.03
Beta
1.07
P/E (TTM)
15.04×
Forward P/E
12.83×
PEG Ratio
1.36
Price/Book
3.61×
Dividend Yield
3.44%
EPS (TTM)
$12.52
Forward EPS
$14.66
TTM Revenue
$73.10 B
TTM Net Income
$7.79 B
Profit Margin
10.66%
Operating Margin
16.96%
EBITDA Margin
17.7%
Gross Margin
32.0%
Net Profit Margin
10.66%
Return on Equity (ROE)
24.41%
Return on Assets (ROA)
10.90%
Q3 FY26 Revenue
$18,718 M
Q3 FY26 Gross Profit
$6,134 M
Q3 FY26 Operating Income
$3,175 M
Q3 FY26 Net Income
$2,339 M
Q3 FY26 Diluted EPS
$3.80
Q2 FY26 Revenue
$18,044 M
Q2 FY26 Diluted EPS
$2.93
Q1 FY26 Revenue
$18,742 M
Q4 FY25 Revenue
$17,596 M
Q3 FY25 Revenue
$17,728 M
Q1 FY26 Unusual Charges
$308 M
Q4 FY25 Unusual Charges
$615 M
Total Assets (May-26)
$68,807 M
Cash & Equivalents (May-26)
$10,165 M
Total Debt (May-26)
$8,389 M
Long-Term Debt (May-26)
$5,029 M
Stockholders' Equity (May-26)
$31,891 M
Goodwill (May-26)
$25,323 M
Goodwill / Total Assets
36.8%
Current Ratio
1.34×
Tangible Book Value
$4.07 B
TTM FCF
$12.09 B
FCF / Revenue
16.5%
Q3 FY26 Operating Cash Flow
$3,786 M
Q3 FY26 CapEx
($186) M
Q3 FY26 Free Cash Flow
$3,600 M
Q3 FY26 Acquisitions
($1,036) M
Q3 FY26 Dividends Paid
($995) M
Q3 FY26 Buybacks
($1,184) M
Annual Dividends
~$4.0 B
Annual Buybacks
~$6.5 B
Diluted Share Count Reduction
2.3%
Annualized Dividend Per Share
$6.48
Combined Shareholder Yield
9-11%
Effective Tax Rate
~24%
D&A
~$300 M/quarter
Book Value Per Share
$52.12
AI Practitioners Trained
50,000+
Strengths
Concerns
Accenture is a Dublin-headquartered global IT services giant generating $73.1B in trailing revenue with exceptional free cash flow of $12.09B (16.5% margin) and top-quartile 24.4% ROE, while returning 9-11% annually to shareholders through dividends and aggressive buybacks. The stock trades at a cyclical discount of 12.8× forward P/E versus its historical 22-25× range, with Q3 FY26 showing revenue reacceleration to +5.6% YoY from a trough of +1.0%, suggesting the post-pandemic consulting slowdown may be bottoming. Key risks include AI cannibalization of billable work, $25.3B in goodwill (37% of assets) creating impairment exposure, high FX sensitivity from >50% international revenue, and macro pressure on U.S. enterprise IT spending — while key catalysts include the AI services monetization tailwind, strong federal sector backlog, and continued FCF-powered buybacks providing valuation support.
Macro: The dominant macro theme is "higher-for-longer" rates with 89% probability of zero Fed cuts in 2026 (Polymarket), as crypto, gold, and silver all decline on inflation concerns. US recession probability is low at 8% (−1pp WoW), consistent with soft-landing/no-landing scenario. HPE earnings beat priced at 92% suggests enterprise IT hardware spending is holding up, mildly positive for ACN's adjacent services demand.